<DOC>
	<DOCNO>NCT01996761</DOCNO>
	<brief_summary>This study , E-COMPASS phase IV clinical trial design multicenter , randomize , double-blind , placebo-controlled , parallel-group study . This study enroll 75 subacute stroke patient unilateral motor dysfunction . Primary objective demonstrate efficacy porcine brain peptide improve motor recovery measure improvement ratio Fugl-Meyer assessment ( ( score FMA 3 week - score FMA baseline ) / score FMA baseline ) patient subacute stroke .</brief_summary>
	<brief_title>Effects Cerebrolysin Motor Recovery Patients With Subacute Stroke</brief_title>
	<detailed_description />
	<mesh_term>Cerebrolysin</mesh_term>
	<criteria>1 . 1st cortical subcortical unilateral infarction ( supratentorial lesion ) 2 . Confirmed CT MRI 3 . Subacute stage : le 1 week 4 . Moderate severe motor function involvementtotal FMA : 084 5 . Age : 18 80 year 6 . Inpatients 1 . Progressive unstable stroke 2 . Preexisting active major neurological disease 3 . Preexisting active ( e.g. , chronic medication ) major psychiatric disease , major depression , schizophrenia , bipolar disease , dementia 4 . A history significant alcohol drug abuse prior 3 year 5 . Advanced liver , kidney , cardiac , pulmonary disease 6 . A terminal medical diagnosis consistent survival &lt; 1 year 7 . Substantial decrease alertness time randomization , define score 2 NIH Stroke Scale 8 . Pregnancy lactate ; note negative pregnancy test require patient female reproductive year 9 . Any condition would represent contraindication Cerebrolysin , include allergy Cerebrolysin 10 . Current enrolment another therapeutic study stroke stroke recovery 11 . Total serum bilirubin &gt; 4 mg/dL , alkaline phosphatase &gt; 250 U/L , SGOT/AST &gt; 150 U/L , SGPT/ALT &gt; 150 U/L , creatinine &gt; 3.5 mg/dL ; cardiopulmonary deficit large enough interfere reasonable participation physiotherapy trial . 12 . Previous porcine brain peptide administration history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>